Literature DB >> 14636846

Quantitative analysis of proliferation, apoptosis, and angiogenesis in retinoblastoma and their association with the clinicopathologic parameters.

Hürkan Kerimoğglu1, Hayyam Kiratli, Ayşse Ayhan Dinçtürk, Figen Söylemezoğlu, Sevgül Bilgiç.   

Abstract

PURPOSE: Quantitative analyses of proliferation, apoptosis, and angiogenesis, which may be important for the prognosis of retinoblastoma, were performed and possible associations with some well-known clinicopathologic parameters were investigated.
METHODS: Fifty-three pathology specimens (43 enucleations, 10 exenterations) were evaluated by immunohistochemical methods. The proliferative index was detected by Ki67 antibody staining. The apoptotic index was calculated by the in situ terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) method, and angiogenesis was detected by CD34 antibody staining.
RESULTS: The mean proliferative index was 37.63+/-11.12, the mean apoptotic index was 2.67+/-1.18, and the microvessel density and mean vascular area were determined as 3.14+/-1.4 and 38.73+/-12.70, respectively. Statistical analysis showed that the proliferative index was directly proportional to the tumor dimensions (P=.001). In addition, the tumor dimensions were larger in cases where the apoptotic index was below 2.4% (P=.011). In cases where the apoptotic index was over 2.4%, no metastasis was observed and also a lower proliferative index was found (P=.014).
CONCLUSIONS: Proliferation appears to be more important than apoptosis and angiogenesis in determining the tumor dimensions. The apoptotic index may be an important predictor of metastasis, and may be useful in the follow-up of bilateral cases with 1 eye enucleated.

Entities:  

Mesh:

Year:  2003        PMID: 14636846     DOI: 10.1016/j.jjo.2003.09.002

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  4 in total

1.  Immunohistochemical expression of CD117 and vascular endothelial growth factor in retinoblastoma: possible targets of new therapies.

Authors:  Nermeen S Youssef; Azza M Said
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

2.  Gelatinase expression in retinoblastoma: modulation of LH(BETA)T(AG) retinal tumor development by anecortave acetate.

Authors:  M Livia Bajenaru; Yolanda Piña; Timothy G Murray; Colleen M Cebulla; William Feuer; Maria-Elena Jockovich; Maria-Encarna Marin Castaño
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-27       Impact factor: 4.799

3.  Clinicopathological Findings of Retinoblastoma: A 10-Year Experience from a Tertiary Hospital in Kampala, Uganda.

Authors:  James Joseph Yahaya; Belson Rugwizangoga; Alex Mremi; Asafu Munema
Journal:  J Ophthalmol       Date:  2019-06-16       Impact factor: 1.909

4.  Expression of Ki67 as detected by MIB-1 and its association with histopathological high-risk factors among patients with retinoblastoma tumour: a cross-sectional study.

Authors:  Edda Am Vuhahula; Shakilu Jumanne; James Yahaya
Journal:  BMJ Open Ophthalmol       Date:  2022-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.